Author:
Gstöttner Christoph,Haselberg Rob,Wuhrer Manfred,Somsen Govert W.,Domínguez-Vega Elena
Reference34 articles.
1. Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC (2005) Monoclonal antibody successes in the clinic. Nat Biotechnol 23(9):1073–1078
2. Kaplon H, Reichert JM (2019) Antibodies to watch in 2019. MAbs 11(2):219–238
3. Schirrmacher V (2019) From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment (review). Int J Oncol 54(2):407–419
4. Chames P, Van Regenmortel M, Weiss E, Baty D (2009) Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol 157(2):220–233
5. Liu H, Ponniah G, Zhang H-M, Nowak C, Neill A, Gonzalez-Lopez N, Patel R, Cheng G, Kita AZ, Andrien B (2014) In vitro and in vivo modifications of recombinant and human IgG antibodies. MAbs 6(5):1145–1154